UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC increased its holdings in shares of Ventas, Inc. (NYSE:VTR – Free Report) by 5.5% during the 2nd quarter, Holdings Channel.com reports. The fund owned 4,981,404 shares of the real estate investment trust’s stock after buying an additional 258,859 shares during the period. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC’s holdings in Ventas were worth $442,349,000 as of its most recent filing with the Securities & Exchange Commission.
Other large investors have also recently bought and sold shares of the company. BlackRock Inc. acquired a new stake in shares of Ventas during the 2nd quarter worth approximately $4,953,439,000. State Street Corp grew its stake in Ventas by 2.5% during the 4th quarter. State Street Corp now owns 29,662,635 shares of the real estate investment trust’s stock worth $2,309,234,000 after buying an additional 735,620 shares during the last quarter. Geode Capital Management LLC increased its position in Ventas by 3.8% in the fourth quarter. Geode Capital Management LLC now owns 12,988,943 shares of the real estate investment trust’s stock worth $1,001,447,000 after buying an additional 475,633 shares during the period. Price T Rowe Associates Inc. MD increased its position in Ventas by 27.9% in the fourth quarter. Price T Rowe Associates Inc. MD now owns 9,176,254 shares of the real estate investment trust’s stock worth $710,060,000 after buying an additional 2,000,341 shares during the period. Finally, Capital World Investors bought a new stake in Ventas in the fourth quarter valued at $594,116,000. Institutional investors own 94.18% of the company’s stock.
Insider Buying and Selling at Ventas
In other news, Director Michael J. Embler bought 2,500 shares of the stock in a transaction that occurred on Wednesday, June 3rd. The shares were purchased at an average cost of $78.81 per share, with a total value of $197,025.00. Following the completion of the acquisition, the director directly owned 19,202 shares in the company, valued at approximately $1,513,309.62. The trade was a 14.97% increase in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. 0.53% of the stock is currently owned by company insiders.
Ventas Price Performance
Ventas (NYSE:VTR – Get Free Report) last issued its quarterly earnings results on Wednesday, July 29th. The real estate investment trust reported $0.97 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.96 by $0.01. Ventas had a return on equity of 1.99% and a net margin of 4.08%.The firm had revenue of $1.73 billion during the quarter, compared to analyst estimates of $1.68 billion. During the same period last year, the company posted $0.87 EPS. The firm’s quarterly revenue was up 21.7% on a year-over-year basis. Equities research analysts anticipate that Ventas, Inc. will post 3.89 earnings per share for the current fiscal year.
Analyst Upgrades and Downgrades
VTR has been the topic of several recent research reports. Royal Bank Of Canada lifted their price objective on shares of Ventas from $98.00 to $99.00 and gave the company an “outperform” rating in a research report on Friday, August 14th. Scotiabank dropped their price target on shares of Ventas from $95.00 to $88.00 and set a “sector perform” rating on the stock in a research note on Thursday, June 18th. Weiss Ratings raised Ventas from a “hold (c+)” rating to a “buy (b-)” rating in a report on Tuesday, July 21st. The Goldman Sachs Group reiterated a “buy” rating and set a $110.00 price objective on shares of Ventas in a research report on Tuesday, May 19th. Finally, KeyCorp increased their price objective on Ventas from $90.00 to $95.00 and gave the stock an “overweight” rating in a report on Thursday, May 7th. Fourteen analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company. According to data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average price target of $98.00.
View Our Latest Research Report on Ventas
Ventas Profile
Ventas, Inc (NYSE: VTR) is a real estate investment trust (REIT) that specializes in healthcare-related real estate. The company acquires, owns and manages a diversified portfolio of properties serving the healthcare continuum, including senior housing communities, skilled nursing facilities, medical office buildings, life science and research centers, and other properties leased to healthcare providers and operators. Ventas generates revenue through long-term leases, property management and selective development activities focused on meeting the real estate needs of the healthcare sector.
Ventas’ business model combines property ownership with active asset management and capital markets activity.
Further Reading
- Five stocks we like better than Ventas
- Strike a Balance Between Growth and Stability With These 3 Names Ready to Rally
- Rubrik’s AI Security Bet Could Power the Next Leg Higher
- Apple’s Foldable iPhone Could Be a Catalyst, But Not a Cure-All
- Snowflake Is Up Nearly 50% in 2026—What Are Short Sellers Betting Against?
Want to see what other hedge funds are holding VTR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Ventas, Inc. (NYSE:VTR – Free Report).
Receive News & Ratings for Ventas Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ventas and related companies with MarketBeat.com's FREE daily email newsletter.
